TORI STRICKLER: Open Payments
NPI 1972172518 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 17 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $0 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $123 |
| ACADIA Pharmaceuticals Inc | 1 | $111 |
| Genentech USA, Inc. | 2 | $56 |
| ARGENX US, INC. | 2 | $55 |
| Celgene Corporation | 2 | $42 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| MDD US Operations, LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: NUPLAZID, QULIPTA, Ocrevus Zunovo, ZEPOSIA, CREXONT, AUSTEDO XR, VYALEV, UBRELVY.
Industry payments across NE — which companies pay providers there.
